GUSTAVO ENRIQUE FORS RODRIGUEZ

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry EDINBURG, TX NPI 1821355348

General Payments — all program years on this page

$1,858.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $319.76 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $208.2713
Education $111.491

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $157.025
Janssen Pharmaceuticals, Inc $44.172
ABBVIE INC. $41.132
Alkermes, Inc. $28.872
Novo Nordisk AS $20.891
Neurocrine BioSciences, Inc. $14.401
ITI, Inc. $13.281

By program year

Program yearAmountRecords
2018 $234.867
2019 $561.1622
2020 $75.305
2022 $251.547
2023 $416.2116
2024 $319.7614

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078198373 Janssen Pharmaceuticals, Inc $19.98 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078198377 Janssen Pharmaceuticals, Inc $24.19 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096563971 Novo Nordisk Inc $20.89 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103744105 ABBVIE INC. $21.41 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103744107 ABBVIE INC. $19.72 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120500054 Alkermes, Inc. $13.93 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120500056 Alkermes, Inc. $14.94 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143225804 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.28 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150876676 Neurocrine Biosciences, Inc. $14.40 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151698453 Teva Pharmaceuticals USA, Inc. $16.77 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151698643 Teva Pharmaceuticals USA, Inc. $111.49 05/15/2024 Education Undisputed 01/23/2026 View at CMS
1151698984 Teva Pharmaceuticals USA, Inc. $10.86 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151699017 Teva Pharmaceuticals USA, Inc. $2.82 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151699022 Teva Pharmaceuticals USA, Inc. $15.08 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.